HPV-induced oropharyngeal cancer, immune response and response to therapy
- PMID: 19628331
- DOI: VSports app下载 - 10.1016/j.canlet.2009.06.026
HPV-induced oropharyngeal cancer, immune response and response to therapy
Abstract
Approximately 25% of head and neck squamous cell carcinoma (HNSCC) worldwide are associated with high-risk human papillomaviruses (HPV). HPV-positive HNSCCs have a more favorable outcome and greater response to therapy. While chronic HPV infection allows for the evolution of immune evasion mechanisms, viral antigens can still elicit an immune response. Moreover, a robust lymphocytic response is associated with better prognosis in a variety of tumor types including head and neck cancer. This article outlines several mechanisms whereby the observed improved response of HPV-positive tumors to radiotherapy may be related to enhancement of the immune response following radiotherapy VSports手机版. .
2009 Elsevier Ireland Ltd. All rights reserved V体育安卓版. .
Publication types (V体育官网)
- V体育ios版 - Actions
"V体育安卓版" MeSH terms
- "VSports手机版" Actions
- "VSports" Actions
- "V体育官网" Actions
- "V体育安卓版" Actions
VSports手机版 - Substances
- "V体育平台登录" Actions
LinkOut - more resources
Full Text Sources
VSports最新版本 - Medical
